• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠期间低抗 RhD IgG-Fc 岩藻糖化:预测胎儿和新生儿溶血病严重程度的新变量。

Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn.

机构信息

Department of Experimental Immunohaematology, Sanquin Research, Amsterdam and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Br J Haematol. 2014 Sep;166(6):936-45. doi: 10.1111/bjh.12965. Epub 2014 Jun 7.

DOI:10.1111/bjh.12965
PMID:24909983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4282073/
Abstract

Haemolytic disease of the fetus and newborn (HDFN) may occur when maternal IgG antibodies against red blood cells (RBCs), often anti-RhD (anti-D) antibodies, cross the placenta and mediate the destruction of RBCs via phagocytic IgG-Fc-receptors (FcγR). Clinical severity is not strictly related to titre and is more accurately predicted by the diagnostically-applied monocyte-based antibody-dependent cellular cytotoxicity (ADCC), a sensitive test with relatively low specificity. This suggests that other factors are involved in the pathogenesis of HDFN. Binding of IgG to FcγR requires the N-linked glycan at position 297 in the IgG-Fc-region, consisting of several different glycoforms. We therefore systematically analysed IgG-derived glycopeptides by mass spectrometry from 70 anti-D IgG1 antibodies purified from the plasma of alloimmunized pregnant women. This revealed a variable decrease in Fc-fucosylation in the majority of anti-D IgG1 (even down to 12%), whereas the total IgG of these patients remained highly fucosylated, like in healthy individuals (>90%). The degree of anti-D fucosylation correlated significantly with CD16 (FcγRIIIa)-mediated ADCC, in agreement with increased affinity of defucosylated IgG to human FcγRIIIa. Additionally, low anti-D fucosylation correlated significantly with low fetal-neonatal haemoglobin levels, thus with increased haemolysis, suggesting IgG-fucosylation to be an important pathological feature in HDFN with diagnostic potential.

摘要

胎儿和新生儿溶血病 (HDFN) 可能发生在母体 IgG 抗体针对红细胞 (RBC) 时,通常是抗 RhD(抗-D)抗体,通过吞噬 IgG-Fc-受体 (FcγR) 穿过胎盘并介导 RBC 破坏。临床严重程度与效价不严格相关,通过应用于诊断的基于单核细胞的抗体依赖性细胞毒性 (ADCC) 更准确地预测,这是一种具有相对低特异性的敏感测试。这表明 HDFN 的发病机制还涉及其他因素。IgG 与 FcγR 的结合需要 IgG-Fc 区中位置 297 的 N-连接聚糖,由几种不同的糖型组成。因此,我们通过质谱法从 70 种从同种免疫孕妇血浆中纯化的抗-D IgG1 抗体中系统地分析了 IgG 衍生的糖肽。这表明大多数抗-D IgG1 的 Fc 岩藻糖基化程度可变下降(甚至下降到 12%),而这些患者的总 IgG 仍高度岩藻糖基化,与健康个体相似(>90%)。抗-D 岩藻糖基化的程度与 CD16(FcγRIIIa)介导的 ADCC 显著相关,这与去岩藻糖基化 IgG 与人 FcγRIIIa 的亲和力增加一致。此外,低抗-D 岩藻糖基化与胎儿新生儿血红蛋白水平低显著相关,从而与溶血增加相关,表明 IgG 岩藻糖基化为 HDFN 的重要病理特征并具有诊断潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b1/4282073/e7322b14818a/bjh0166-0936-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b1/4282073/b89d26c8f133/bjh0166-0936-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b1/4282073/0e46e71e3fad/bjh0166-0936-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b1/4282073/15d257132930/bjh0166-0936-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b1/4282073/ad8e9608cdb6/bjh0166-0936-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b1/4282073/e7322b14818a/bjh0166-0936-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b1/4282073/b89d26c8f133/bjh0166-0936-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b1/4282073/0e46e71e3fad/bjh0166-0936-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b1/4282073/15d257132930/bjh0166-0936-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b1/4282073/ad8e9608cdb6/bjh0166-0936-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28b1/4282073/e7322b14818a/bjh0166-0936-f5.jpg

相似文献

1
Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn.妊娠期间低抗 RhD IgG-Fc 岩藻糖化:预测胎儿和新生儿溶血病严重程度的新变量。
Br J Haematol. 2014 Sep;166(6):936-45. doi: 10.1111/bjh.12965. Epub 2014 Jun 7.
2
Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn.抗原特异性决定了抗红细胞 IgG-Fc 同种异体抗体的糖基化,从而决定了胎儿和新生儿溶血病的严重程度。
Br J Haematol. 2017 Feb;176(4):651-660. doi: 10.1111/bjh.14438. Epub 2016 Nov 28.
3
A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy.妊娠期间血小板同种抗体 IgG1-Fc 岩藻糖基化显著缺乏。
Blood. 2014 Jan 23;123(4):471-80. doi: 10.1182/blood-2013-09-527978. Epub 2013 Nov 15.
4
Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy.来自 23 个人源和啮齿动物细胞系的抗-D 单克隆抗体表现出不同的 IgG Fc-糖基化谱,决定了它们的临床疗效。
Sci Rep. 2020 Jan 30;10(1):1464. doi: 10.1038/s41598-019-57393-9.
5
Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia.抗血小板 IgG 的糖基化模式在怀孕期间是稳定的,并可预测同种免疫性血小板减少症的临床结局。
Br J Haematol. 2016 Jul;174(2):310-20. doi: 10.1111/bjh.14053. Epub 2016 Mar 28.
6
Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.妊娠期间红细胞同种免疫、胎儿溶血病的发生免疫学原理以及RhD阴性女性RhD同种免疫的预防。
Ceska Gynekol. 2020 Winter;85(6):408-416.
7
Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.预测胎儿和新生儿溶血病严重程度的实验室检测方法。
Transpl Immunol. 2002 Aug;10(2-3):191-8. doi: 10.1016/s0966-3274(02)00065-5.
8
Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.母体FcR阻断性IgG同种抗体HLA-DR对新生儿Rh D溶血病保护作用的证据。
Vox Sang. 1993;65(1):55-8. doi: 10.1111/j.1423-0410.1993.tb04525.x.
9
A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn.预测胎儿和新生儿溶血病严重程度的体外试验比较
Vox Sang. 1998;74 Suppl 2:375-83. doi: 10.1111/j.1423-0410.1998.tb05445.x.
10
Disease severity in subsequent pregnancies with RhD immunization: A nationwide cohort.RhD 免疫后后续妊娠的疾病严重程度:一项全国性队列研究。
Vox Sang. 2024 Aug;119(8):859-866. doi: 10.1111/vox.13651. Epub 2024 May 21.

引用本文的文献

1
IgG glycosylation profiling of systemic lupus erythematosus using lectin microarray.使用凝集素微阵列对系统性红斑狼疮进行IgG糖基化分析。
Lupus Sci Med. 2025 Apr 5;12(1):e001413. doi: 10.1136/lupus-2024-001413.
2
Acquisition of Fc-afucosylation of PfEMP1-specific IgG is age-dependent and associated with clinical protection against malaria.疟原虫红细胞膜蛋白1特异性IgG的Fc-岩藻糖基化的获得具有年龄依赖性,并与疟疾的临床保护相关。
Nat Commun. 2025 Jan 2;16(1):237. doi: 10.1038/s41467-024-55543-w.
3
Fc mutagenesis enhances the functionality of anti-RhD monoclonal antibodies.

本文引用的文献

1
IgG-effector functions: "the good, the bad and the ugly".IgG效应功能:“好坏参半”。
Immunol Lett. 2014 Aug;160(2):139-44. doi: 10.1016/j.imlet.2014.01.015. Epub 2014 Feb 1.
2
Anti-rhesus D prophylaxis in pregnant women is based on sialylated IgG antibodies.孕妇的抗D预防基于唾液酸化IgG抗体。
F1000Res. 2013 Aug 9;2:169. doi: 10.12688/f1000research.2-169.v1. eCollection 2013.
3
Lack of galactosylation enhances the pathogenic activity of IgG1 but Not IgG2a anti-erythrocyte autoantibodies.缺乏半乳糖基化增强 IgG1 但不增强 IgG2a 抗红细胞自身抗体的致病活性。
Fc诱变增强了抗RhD单克隆抗体的功能。
Blood Adv. 2025 Apr 8;9(7):1522-1533. doi: 10.1182/bloodadvances.2024015082.
4
Fc-Afucosylation of VAR2CSA-Specific Immunoglobulin G and Clinical Immunity to Placental Plasmodium falciparum Malaria.VAR2CSA特异性免疫球蛋白G的Fc-岩藻糖基化与胎盘恶性疟原虫疟疾的临床免疫
J Infect Dis. 2024 Nov 25. doi: 10.1093/infdis/jiae529.
5
Hemolytic disease of the fetus and newborn-a perspective of immunohematology.胎儿及新生儿溶血病——免疫血液学视角
Hematol Transfus Cell Ther. 2024 Nov;46 Suppl 5(Suppl 5):S246-S257. doi: 10.1016/j.htct.2024.04.122. Epub 2024 Aug 18.
6
PfEMP1 and var genes - Still of key importance in Plasmodium falciparum malaria pathogenesis and immunity.PfEMP1 和 var 基因——在恶性疟原虫致病机制和免疫中仍然具有关键重要性。
Adv Parasitol. 2024;125:53-103. doi: 10.1016/bs.apar.2024.02.001. Epub 2024 Mar 23.
7
The role of antibody glycosylation in autoimmune and alloimmune kidney diseases.抗体糖基化在自身免疫和同种免疫性肾脏疾病中的作用。
Nat Rev Nephrol. 2024 Oct;20(10):672-689. doi: 10.1038/s41581-024-00850-0. Epub 2024 Jul 3.
8
GlYcoLISA: antigen-specific and subclass-specific IgG Fc glycosylation analysis based on an immunosorbent assay with an LC-MS readout.GlYcoLISA:基于免疫吸附测定和 LC-MS 读数的抗原特异性和亚类特异性 IgG Fc 糖基化分析。
Nat Protoc. 2024 Jun;19(6):1887-1909. doi: 10.1038/s41596-024-00963-7. Epub 2024 Feb 21.
9
Impact of structural modifications of IgG antibodies on effector functions.IgG 抗体结构修饰对效应功能的影响。
Front Immunol. 2024 Jan 8;14:1304365. doi: 10.3389/fimmu.2023.1304365. eCollection 2023.
10
Immunomodulation of Antibody Glycosylation through the Placental Transfer.通过胎盘转运对抗体糖基化的免疫调节。
Int J Mol Sci. 2023 Nov 26;24(23):16772. doi: 10.3390/ijms242316772.
J Immunol. 2014 Jan 15;192(2):581-8. doi: 10.4049/jimmunol.1302488. Epub 2013 Dec 13.
4
A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy.妊娠期间血小板同种抗体 IgG1-Fc 岩藻糖基化显著缺乏。
Blood. 2014 Jan 23;123(4):471-80. doi: 10.1182/blood-2013-09-527978. Epub 2013 Nov 15.
5
Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation.免疫球蛋白 G 的半乳糖基化与怀孕期间类风湿关节炎的改善相关,且与唾液酸化无关。
J Proteome Res. 2013 Oct 4;12(10):4522-31. doi: 10.1021/pr400589m. Epub 2013 Sep 24.
6
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity.HIV 特异性抗体 Fc 糖基化的自然变异影响抗病毒活性。
J Clin Invest. 2013 May;123(5):2183-92. doi: 10.1172/JCI65708. Epub 2013 Apr 8.
7
High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides.利用糖肽的质谱法进行高通量 IgG Fc N-糖基化分析。
J Proteome Res. 2013 Feb 1;12(2):821-31. doi: 10.1021/pr300887z. Epub 2013 Jan 18.
8
Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G.比较胎儿和母体免疫球蛋白 G 的 Fc 糖基化。
Glycoconj J. 2013 Feb;30(2):147-57. doi: 10.1007/s10719-012-9381-6. Epub 2012 May 10.
9
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.Fc 受体靶向疗法治疗炎症、癌症及其他疾病。
Nat Rev Drug Discov. 2012 Mar 30;11(4):311-31. doi: 10.1038/nrd2909.
10
Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential.FcRn 介导的转运竞争导致人 IgG3 的半衰期较短,并提供了治疗潜力。
Nat Commun. 2011 Dec 20;2:599. doi: 10.1038/ncomms1608.